Global Microarray Market
Healthcare Services

Microarray Market Forecast Through 2030 Highlighting Market Patterns And Developments

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The Microarray Market Progress Between 2026 And 2030?

The microarray market has experienced robust expansion in recent years. This market is projected to expand from $5.62 billion in 2025 to $6.17 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.8%. Historically, this expansion has been driven by factors such as the increasing adoption of gene expression profiling, advancements in dna sequencing technologies, a surge in the application of microarrays in cancer research, the broadening of drug discovery programs, and the increasing prevalence of genetic disorders.

The microarray market is projected to experience substantial expansion over the coming years. Its value is anticipated to reach $9.1 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.2%. This projected growth during the forecast period stems from factors such as the increasing demand for personalized medicine, enhancements in bioinformatics processing tools, the rising incorporation of automation into microarray workflows, broadening applications in toxicological testing, and the expanding requirement for high-throughput genomic analysis. Key trends expected within this period encompass genomics-driven microarray optimization, cloud-based data processing specifically for microarray analysis, AI-enhanced gene expression interpretation, automated microarray manufacturing systems, and IoT-enabled sample tracking and monitoring.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10742&type=smp

What Significant Factors Are Influencing The Microarray Market Expansion?

The escalating occurrence of cancer cases is anticipated to propel the expansion of the microarray market in the coming years. Cancer is characterized as a condition where certain cells within the body proliferate uncontrollably and disseminate to other bodily regions. The increase in cancer diagnoses primarily stems from the growing prevalence of established cancer risk factors, exposure to particular chemicals, an aging demographic, and common cancers such as breast cancer, lung cancer, and bronchial cancer. Microarray technology plays a crucial role here, allowing researchers to pinpoint alterations in gene expression that may be associated with cancer. For instance, in January 2023, the American Cancer Society, a US-based voluntary health organization, reported that approximately 9,910 children in the US under the age of 15 were diagnosed with cancer, and roughly 1,040 children under the age of 15 died from cancer in 2023. Consequently, the upward trend in cancer incidence is fueling the growth of the microarray market.

How Are Different Segments Classified In The Microarray Market Segment Analysis?

The microarray market covered in this report is segmented –

1) By Type: DNA Microarray, Protein Microarray, Other Types

2) By Application: Disease Diagnosis, Cancer Genomic Analysis, Drug Discovery, Genomic Sequencing, Expression Analysis, Toxicological Research, Other Applications

3) By End-User: Pharmaceutical Industry, Biotechnology Industry, Academic and Research Laboratories, Other End-Users

Subsegments:

1) By DNA Microarray: CDNA Microarray, Oligonucleotide Microarray, SNP Microarray, Comparative Genomic Hybridization (CGH) Microarray

2) By Protein Microarray: Antibody Microarray, Antigen Microarray, Receptor Microarray, Enzyme Microarray

3) By Other Types: Cell Microarray, Tissue Microarray, RNA Microarray

What Trends Are Affecting The Direction Of The Microarray Market?

Leading companies in the microarray sector are concentrating their efforts on developing chromosomal microarrays to solidify their standing in the market. Chromosomal Microarray Analysis (CMA) stands as a leading transformative technology in genomic medicine, significantly advancing diagnostic capabilities. For example, in August 2023, Thermo Fisher Scientific, Inc., a US-based provider of analytical instruments, life sciences solutions, specialty diagnostics, laboratory, pharmaceutical, and biotechnology services, unveiled the Applied Biosystems CytoScan HD Accel array. This new chromosomal microarray is engineered to boost productivity, efficiency, and profitability in cytogenetic research laboratories. A key feature of this innovative array is its industry-leading two-day turnaround time, marking a significant improvement in the field. The Applied Biosystems CytoScan HD Accel array conducts a thorough analysis of the entire human genome. With enhanced coverage spanning over 5,000 critical genomic regions, it offers invaluable insights into chromosomal variants. This advanced technology proves beneficial for a wide array of applications, including prenatal and postnatal research, as well as cancer-related investigations.

Who Are The Companies Driving Activity In The Microarray Market?

Major companies operating in the microarray market are Agilent Technologies Inc., Arrayit Corporation, Bio-Rad Laboratories Inc., Danaher Corporation, GE Healthcare Inc., Illumina Inc., Merck KGaA, Microarray Inc., PerkinElmer Inc., Thermo Fisher Scientific Inc., Molecular Devices LLC, RayBiotech Life Inc., Schott Minifab AG, Full Moon Biosystems Inc., CapitalBio Technology Co. Ltd., Roche Diagnostics Ltd., Affymetrix Inc., SCIENION AG, NextGen Sciences Inc., PathogenDx Inc., BioGenomics Limited, BioMicro Systems Inc., Biostatus Limited, Biotechrabbit GmbH, INanoBio Inc.

Get The Full Microarray Market Report:

https://www.thebusinessresearchcompany.com/report/microarray-global-market-report

Which Region Has The Greatest Market Share In The Microarray Market?

North America was the largest region in the microarray market in 2025.Asia-Pacific is expected to be the fastest-growing region in the global microarray market report during the forecast period. The regions covered in the microarray market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Microarray Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/microarray-global-market-report

Browse Through More Reports Similar to the Global Microarray Market 2026, By The Business Research Company

Cone Beam Computed Tomography Market Report 2026

https://www.thebusinessresearchcompany.com/report/cone-beam-computed-tomography-global-market-report

Medical Imaging Market Report

https://www.thebusinessresearchcompany.com/report/medical-imaging-global-market-report

Computed Tomography Ct Scanner Market Report

https://www.thebusinessresearchcompany.com/report/computed-tomography-ct-scanner-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model